Breast Cancer

A research study, WISDOM, is currently underway to improve breast cancer diagnosis timing and outcomes by comparing annual mammography with a personalized screening approach to identify women at highest risk for fast-growing cancers.

The addition of inavolisib to palbociclib and fulvestrant more than doubled PFS for certain patients with advanced breast cancer, according to results of a randomized phase 3 trial.

Researchers reported beneficial effects of a supervised exercise intervention on breast cancer outcomes, according to preliminary findings from the OptiTrain trial presented at ESMO Congress.

Breast cancer survivors who participated in a remote personalized exercise program experienced modest improvements in quality of life, according to results from the eMouvoir trial presented at ESMO Congress.

A telephone-based weight loss intervention significantly increased moderate or vigorous physical activity in patients with breast cancer with overweight/obesity, according to a breast cancer weight loss trial presented at ESMO Congress.

A retrospective study revealed that industry-sponsored clinical trials have enrolled significantly more participants than federally sponsored trials over the past decade.

For many oncologists, the use of mastectomy to treat breast cancer cases can be a difficult subject to approach with patients.

Women who breastfeed after undergoing treatment for breast cancer are not at elevated risk for recurrence or new breast cancers, two studies presented at ESMO Congress showed.

Individuals with cancer expressed a preference for early and frequent provider-initiated discussions about financial toxicity, according to study findings.

Laura J. van ’t Veer, PhD, will receive the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 10-13.